GetTopicDetailResponse(id=625912418676, topicName=澤妥珠單抗, introduction=, content=NSCLC 胰腺癌 NRG1融合 澤妥珠單抗, image=null, comments=0, allHits=314, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Feb 13 13:55:42 CST 2025, time=2025-02-13, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=501437, tagList=[TagDto(tagId=501437, tagName=澤妥珠單抗)], ipAttribution=湖北省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2251771, encodeId=58e02251e71c9, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a> <a href='/topic/show?id=9679130427e' target=_blank style='color:#2F92EE;'>#NRG1融合#</a> <a href='/topic/show?id=625912418676' target=_blank style='color:#2F92EE;'>#澤妥珠單抗#</a>, objectTitle=NEJM | 澤妥珠單抗：精準(zhǔn)治療NRG1融合陽(yáng)性NSCLC和胰腺癌新突破, objectType=article, longId=863116, objectId=6c1d86311695, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250213/1739420925501_6145188.png, objectUrl=/article/show_article.do?id=6c1d86311695, replyNumber=0, likeNumber=39, createdTime=2025-02-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=湖北省, moduleDTOList=[ModuleDTO(moduleId=6c1d86311695, moduleTitle=NEJM | 澤妥珠單抗：精準(zhǔn)治療NRG1融合陽(yáng)性NSCLC和胰腺癌新突破, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6c1d86311695)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-13發(fā)表于湖北省
